Morphic Therapeutic
Otello Stampacchia, PhD founded Omega Funds in 2004 and leads the firm’s investor relations and strategic initiatives.
This person is not in the org chart
This person is not in any offices
Morphic Therapeutic
1 followers
Morphic Therapeutic is leading the development of a new generation of oral integrin drugs, informed by decades of world-leading expertise and a unique integrin discovery platform.